ACHE and Alzheimer disease: While acetylcholinesterase inhibitors are used therapeutically to manage AD symptoms, chronic exposure to organophosphates leads to prolonged cholinergic dysfunction, oxidative stress, and neuroinflammation, contributing to neurodegenerative processes which differ from controlled, short-term therapeutic use.